FDA warns 1ViZn that Velocity ingredient DMBA is adulterated product | Kristensen Weisberg, LLP
FDA warns 1ViZn that Velocity ingredient DMBA is adulterated product - Employment Law -- Employee - Kristensen Weisberg, LLP
Logo 310-984-1297
12540 Beatrice Street Suite 200, Los Angeles CA 90066
Se Habla Español
Contact Us Today 310-984-1297

Los Angeles Law Blog

By John Kristensen of Kristensen Weisberg, LLP posted in Employment Law -- Employee on Thursday, April 30, 2015.
FDA warns 1ViZn that Velocity ingredient DMBA is adulterated product

On April 24, 2015, the FDA sent a warning letter to the Utah manufacturer of “Velocity” that it considered its supplement “adulterated” because it containing a stimulant known as DMBA or AMP. The FDA contends that even if DMBA (also known as 1,3-Dimethylbutylamine, DMBA, 2-amino-4-methylpentane, AMP citrate, and 4-methyl-2-pentanamine) was a “new dietary” ingredient” there has been no notification under 21 CFR 190.6.  1ViZN’s Weight Loss Supplement Velocity from ReviewVelocity on Vimeo. Kristensen Weisberg, LLP have been handling product cases for over a decade with a track record of success.   We recently filed a substantial complaint in New Jersey State Court against manufactures and sellers of supplements containing the now banned DMAA.  If you were injured by Velocity or another supplement, give us a call at (310) 507-7924 , or contact us at klg @kristensenlaw.com for a free consultation.

Tags: